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Background: Increasing metabolism is a primary focus of many commercially available dietary supplements
marketed to support weight management. Caffeine (e.g. anhydrous and herbal) and green tea are key ingredients
in such products, augmenting resting energy expenditure (REE) and improving reported mood states (alertness,
fatigue, focus, etc.). The purpose of this study was to evaluate the effects of a thermogenic dietary supplement
(DBX) on REE, respiratory exchange ratio (RER), reported measures of alertness, focus, energy, concentration, fatigue,
and hunger, as well as the general safety of the product based on electrocardiogram (ECG) and hemodynamic
responses in habitual caffeine consumers.
Methods: Six male and six female subjects (mean ± SD; 22.50 ± 3.22 years; 76.94 ± 14.78 kg; 22.7 ± 9.5% body fat),
physically active (≥12 months), and moderate habitual caffeine consumers (<200 mg/day) received either two
capsules of DBX containing 340 mg of total caffeine plus green tea extract, yerba mate extract, carnitine tartrate
and other active ingredients or a placebo (PLC) in a double-blinded, crossover design. Heart rate (HR), blood
pressure (BP), REE, RER and perceived mood states were measured at baseline and then hourly for four hours after
ingesting either treatment.
Results: Resting energy expenditure was significantly increased at all four time points and significant increases
were determined for perceived alertness (p = 0.026) and focus (p = 0.05) at hour 1 and for energy at 1 and 2 hours
after treatment for the DBX group (p = 0.008 and p = 0.017, respectively). Additionally, perceived fatigue was
decreased at the hour 1 assessment (p = 0.010). No significant differences were seen between DBX and placebo for
hunger, anxiety, HR, BP, ECG patterns or RER.
Conclusions: The results of this investigation support that the proprietary blend of this thermogenic aid is capable
of increasing REE for four hours post-ingestion while supporting increased focus, alertness, and energy as well as
decreasing fatigue without promoting anxiety or causing significant changes in HR, BP, or ECG measurements in
habitual caffeine consumers.
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Augmentations in overall metabolism and “fat burning”
are two physiological expectations of consumers when
purchasing a thermogenic dietary supplement. One of
the primary reasons for taking a thermogenic aid is to
support weight loss and body leaning [1]. Many of these
products found on the market, and available to the gen-
eral public, contain synthetic caffeine and herbal sources
(e.g. guarana, yerbe mate), green tea extract, and other
purported metabolic-supporting ingredients such as
carnitine and capsaicin (red pepper extract). The most
researched ingredient, caffeine, has been reported to
have several potential ergogenic benefits including in-
creased energy expenditure and weight loss, decreased
body fat, as well as increased performance and a poten-
tial glycogen-sparing effect [2,3]. Green tea extract with
a standardized level of catechins in combination with
caffeine has been shown to significantly increase daily
energy expenditure and fat oxidation over that of caf-
feine alone [4]. Rudelle and associates [5] investigated
the effects of a thermogenic drink containing green tea
catechins, as well as caffeine, on energy expenditure in
lean individuals. The beverage increased resting energy
expenditure (REE) by 4.6% and the authors suggested
that this type of beverage could be beneficial for weight
loss and management. The increase in energy expend-
iture reported by multiple researchers [6-9] positions
caffeine and green tea-containing supplements as a
beneficial tool to offset the reduction in energy expend-
iture associated with weight loss [10-12]. In addition to
affecting metabolism and favoring fat as a fuel source,
many studies have shown that caffeine has an impact on
alertness, fatigue, and other mood states [13-15]. After
ingesting 120 mg of caffeine supplementation, greater
alertness was reported for up to three hours by Mitchell
and colleagues [13] and 40 mg of caffeine combined with
97 mg of L-theanine, the key caffeine analog in tea,
showed improvements in perceived alertness and tired-
ness 20 and 70 minutes after ingestion in an investiga-
tion led by Giesbrecht and associates [14]. Caffeine
levels of 250 mg and 500 mg also decreased reported
tiredness and increased self-reported alertness when
given to nine healthy subjects [15]. One important con-
sideration in caffeine consumption studies is the control
of habitual intake as individuals can become acclimated
to caffeine, thus influencing their physiological responses
to a specific dose.
Seeing these potential benefits for their consumers,
supplement companies have created their own propri-
etary blends for weight management and body leaning
supplements, as well as ergogenic aids containing
caffeine. Many of these products claim to increase
metabolism and “fat burning” either independently, or
in conjunction with the caffeine contained in thesupplement. Because of the popularity of weight man-
agement supplements, researchers have investigated
different thermogenic products to determine their
effectiveness. For instance, Hoffman and colleagues
[16] determined that a commercially available product
containing multiple trademarked ingredient mixtures
demonstrated a trend for increased fat oxidation while
also increasing heart rate (HR), systolic blood pressure
(SBP) and reported levels of tension and confusion
among the supplement group. Another study performed
in 2009 [17] revealed that capsaicin, an active ingredient
in the DBX proprietary blend, statistically increased en-
ergy expenditure and diastolic blood pressure (DBP)
after ingestion but had no influence on fat utilization. A
third investigation [18] revealed a significant effect for
REE, as well as RER and SBP over three hours when
regular coffee drinkers consumed a commercial product
containing roughly 400 mg total caffeine.
Based on these past studies, many thermogenic sup-
plements are successful at increasing energy expend-
iture, but varying doses and combinations of ingredients
may cause different cardiovascular and mood state side
effects. Further product-specific research on thermo-
genic aids is needed to determine levels of effectiveness
and safety for consumers. The purpose of this study was
to evaluate the effects of a commercially available
thermogenic dietary supplement on energy expenditure,
reported measures of alertness, focus, energy, concentra-
tion, fatigue, and hunger, as well as the general tolerance
and safety of the supplement based on ECG and




Six males and six females (mean ± SD; age: 22.50 ± 3.22
years; weight: 76.94 ± 14.78 kg; body fat: 22.7 ± 9.5%)
volunteered for the study conducted in the Human Per-
formance Lab (HPL) at the University of Mary Hardin-
Baylor in Belton, Texas. Participants were required to be
apparently healthy, physically active (regularly participat-
ing in exercise for the previous 12 months), moderate
caffeine users (<200 mg/day), and were excluded from
the study if they had any known metabolic disorders,
were sensitive to caffeine, had a history of pulmonary
disease, hypertension, liver or kidney disease, musculo-
skeletal or neuromuscular disease, neurological disease,
autoimmune disease, or any cancers, peptic ulcers, or
anemia. Taking certain medications, including those for
heart, pulmonary, thyroid, anti-hyperlipidemic, hypogly-
cemic, anti-hypertensive, endocrinologic, psychotropic,
neuromuscular, neurological, or androgenic conditions,
as well as a family history of heart problems, high
blood pressure, and/or stroke, and being pregnant or
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assistants screened and examined participants as well as
obtained a complete medical history to determine if each
participant met the qualification standards. Participants
reported the number of caffeinated beverages (coffee, tea,
soft drink, energy drink, etc.), caffeine containing medica-
tions (NoDoz, Vivarin, etc.) and caffeine containing foods
(candy, chocolate ice cream, etc.) as well as the serving
size (8 oz., 5 oz., etc.) of each reported caffeinated product
they consumed per week on average. Average caffeine
consumption was determined to be 176.59 ± 86.63 mg/
day. Volunteers were required to report any previous or
current use of nutritional supplements, prescription and
non-prescription medications. Participants were instructed
to not change their nutritional supplement/medication
intake over the course of the study and to report any
changes to lab personnel.Instruments
Anthropometric measures
Body composition was determined with the use of
the Discovery QDR Dual-Energy X-ray Absorptiometry
(DEXA) machine (Hologic, Inc., Bedford, MA). Partici-
pants were positioned in a supine position on the DEXA
machine, in either workout shorts or hospital gown, and
were asked to remain still during the entirety of the six
minute scan. Percent body fat (%Fat), fat free mass
(FFM; grams), and fat mass (FM; grams) were collected
from the DEXA report. Height was obtained from the
SECA 242 measuring instrument (242, SECA, Hanover,
MD) and recorded in both centimeters and inches. The
TANITA Body Composition Analyzer (Model TBF-310,
TANITA, Arlington Heights, IL) was utilized to measure
weight in both kilograms and pounds.Resting energy expenditure
REE was measured using a TrueOneW 2400 metabolic
measurement system (ParvoMedics, Sandy, UT). The
metabolic cart was calibrated daily by trained laboratory
assistants according to manufacturer guidelines. During
testing, participants rested in a supine position with a
blanket in a quiet, semi-dark room. A clear hood was
placed over the participant’s head and upper torso area.
REE and respiratory exchange ratio (RER) data were col-
lected from the last 20 minutes of the 25 minute test.
For each breath, mean oxygen uptake (VO2) and carbon
dioxide output (VCO2) were measured and then aver-
aged over 15 second intervals. Flow rate was monitored
by lab assistants during the course of the test and
maintained at a rate of 1–1.2 L/min of expired carbon
dioxide. The test-retest correlations (r) of this metabolic
cart range from 0.814-0.956 [19].Mood state questionnaire
A 5-point Likert scale questionnaire was used to meas-
ure perceived alertness, focus, energy, fatigue, concentra-
tion, and hunger. The participant placed a check mark
in the specific box that correlated with their perceived
mood level for all six categories. The numbers ranged
from one (not feeling that particular mood) to five
(highest level of mood).Hemodynamic assessments
Electrocardiogram (ECG) leads were placed in standard
clinical fashion to reveal 12 leads (I-III, V1-V6, aVR, aVL,
aVF) throughout the testing session. Cardiac rhythm was
monitored through a Quinton Eclipse Premier Electro-
cardiograph (Cardiac Science Corporation, Bothell,
WA). Every five minutes, data were printed from the
12-lead ECG machine and RR interval, RP interval, QRS
duration, and QT interval were recorded. If any abnor-
mal readings/tracing were discovered, a note was added
to the patient’s file. Heart rate, recorded as beats per
minute and SBP and DBP, recorded as mmHg, were
measured at baseline and hourly for four hours after
consuming either treatment.Diet log
Participants were instructed to maintain a diet log for
four days prior to the first testing session, testing day
one, as well as days between testing sessions. Lab
personnel instructed participants to report foods eaten
at breakfast, lunch, and dinner, as well as snacks. They
were also instructed to record the method of preparation
for each food and the quantity eaten (servings, cups, ta-
blespoons, etc.). Trained HPL assistants input the data
from the diet logs into the Food Processor Nutrition and
Fitness Software (ESHA Research, Salem, OR) computer
program, which was used to determine caloric intake
based on reported information from participants.Supplement
Our active supplement Dyma-BurnW Xtreme (Dymatize
Enterprises, LLC, Dallas, TX) contains multiple ingredients
combined to provide metabolic support including caffeine
anhydrous, guarana, yerba mate green tea extract,
L-carnitine L-tartrate (200 mg), pathothenic acid (17 mg),
chromium picolinate (100 mcg) and proprietary blends
containins , AssuriTea™ Green Tea Extract (Kemin Nutri-
tionals, Iowa City, IA), Salvia sclarea, raspberry ketones
and Capsicum Annum extract, plus l-tyrosine, salix alba
(white willow), zingiber officinale (ginger), focus vesiculosus
(bladderwrack), panax ginseng, and BioperineW (black pep-
per extract). The total caffeine and catechin content of the
supplement was 340 mg and 60 mg respectively.
Table 1 Testing day timeline
Testing day timeline
DEXA ×
REE (ending time) × × × × ×
ECG Begins ×
Supplementation ×
BP/HR × × × × ×
Mood State Ques. × × × × ×
−45 min −30 min 0 min 60 min 120 min 180 min 240 min
REE testing began 25 minutes before the end of each hour and lasted for 25 minutes.
HR and BP were recorded at the end of each hour and participants completed a mood state questionnaire at this time point as well. ECG electrodes were placed
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Participants completed medical and exercise history sur-
veys as well as signed an Informed Consent before
beginning the study. Typical caffeine intake, over the
counter drug usage, perceived fatigue, and appetite were
reported along with daily caffeine consumption. All par-
ticipants and paperwork were examined by qualified
laboratory personnel. On the first day of the study, par-
ticipants reported to the HPL at 8:00 am in a 12-hour
fasted state. All testing sessions were held in the morn-
ing hours to reduce changes in REE due to performance
of daily activities and stresses. This study was conducted
in a double-blind, crossover manner with participants
consuming either 2 capsules of a placebo (PLC) or 2
capsules of the active supplement (DBX). Before the ini-
tial treatment, DEXA was performed to assess body
composition. Meanwhile, before either treatment, ECG
electrodes were then positioned by HPL assistants and a
baseline ECG was recorded. A 12 lead ECG printout was
collected every five minutes throughout the testing
period. A baseline metabolic test was conducted prior to
supplementation and REE and RER data were recorded.
After the initial REE session, each subject then con-
sumed the randomly assigned treatment. Post supple-
mentation, REE and RER data was collected from the
last 20 minutes of the metabolic test at 60, 120, 180, and
240 minutes. At the end of testing day one, participants
left the HPL and returned three days later to complete
another testing session identical to the first with the ex-
ception of consuming whichever treatment was not con-
sumed on test day one. A timeline for the testing day
can be seen in Table 1.-100
-50
Baseline 1HR 2HR 3HR 4HR
Figure 1 Resting energy expenditure changes. REE increased
across all time points for DBX (active) ranging from a 123.4 to 147.3
kcal/day increase above baseline values. Changes were statistically
different between groups at all time points post-supplementation.
* indicates statistically significant changes (p ≤ 0.05).Data analysis
All data was analyzed in SPSS using a mixed-factorial
ANOVA [treatment (DBX vs PLC) x time (HR1 vs HR2
vs HR3 vs HR4)]. When a significant interaction was
found, a lower order ANOVA with Bonferroni post-hoc
corrections was used. A Kruskal-Wallis one-way analysisof variance was also used for all survey data. Significance
was set at p ≤ 0.05.Results
REE and RER
A significant group x time interaction for change in
resting energy expenditure (p = 0.001) was determined.
From baseline to hour 4, REE increased by 147.33 ±
83.52 for DBX and 32.17 ± 86.72 kcal/day for PLC
(p = 0.003). Changes in kcal/day for all time points can
be seen in Figure 1. A significant main effect for time
was also reported (p = 0.001). Changes in REE from
baseline for each time point are as follows: hour 1 (DBX:
123.4 ± 78.2 kcal/day vs. PLC: -3.1 ± 88.4 kcal/day), hour
2 (DBX: 125.5 ± 62.2 kcal/day vs. PLC: -20.3 ± 72.6 kcal/
day), hour 3 (DBX: 142.4 ± 101.16 kcal/day vs. PLC: 9 ±
114.77 kcal/day), and hour 4 (DBX: 147.3 ± 83.5 kcal/day
vs. PLC: 32.1 ± 86.7 kcal/day). Changes were significant
(p < .05) between groups at all time points for REE.
There were no significant time or interaction effects for
RER at any time point.
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There were no significant (p > 0.05) group x time inter-
actions and no main effects for time for SBP, DBP, or
HR (Figure 2). There was no significant main effect for
group (p > 0.05). At hour 1, SBP increased by 12.4 ± 11.8
mmHG and 1.75 ± 10.4 mmHG for DBX and PLC, re-
spectively from baseline values. From baseline to hour 2,
SBP increased by 10.0 ± 14.0 mmHg (DBX) versus 0.0 ±
7.9 mmHg (PLC). Hour 3 SBP deviated from baseline by
13.5 ± 22.4 mmHg for DBX and −2.5 ± 8.1 mmHg for
PLC. Hour 4 SBP increased above the baseline mean by
8.3 ± 10.5 mmHg (DBX) and 1.5 ± 10.6 mmHg (PLC).
DBP changes from baseline to hour 1 were 4.8 ± 7.4
mmHg (DBX) versus 0.6 ± 7.9 mmHg (PLC). At hour 2,
DBP changed from baseline by −0.25 ± 13.2 (DBX) and
−1.0 ± 7.2 mmHg (PLC). Hour 3 values for DBP fromFigure 2 Hemodynamic measurement changes. a: Systolic Blood
Pressure did not significantly differ from baseline values at HR1, 2, 3
or 4 for the active supplement group. b: Diastolic blood pressure did
not significantly differ from baseline values at HR1, 2, 3 or 4 for the
active supplement group. c: Heart rate, represented as beats per
minute, was not significantly changed at any time point compared
to baseline measurements for the supplement group.baseline for DBX were 6.7 ± 20.9 mmHg and for PLC
were −4.5 ± 10.1 mmHg. The comparison against DBP
baseline measurement for the DBX group at hour 3 was
1.25 ± 6.8 mmHg and 1.1 ± 11.0 mmHg for the PLC
group. DBX versus PLC comparison to baseline in HR
are as follows: hour 1 (−3.0 ± 6.2 vs. -2.5 ± 5.5 bpm),
hour 2 (−2.9 ± 6.5 vs. -1.0 ± 10.0 bpm), hour 3 (−2.3 ± 5.6
vs. -0.5 ± 8.7 bpm), and hour 4 (−1.4 ± 6.8 vs. -0.3 ± 7.4
bpm). (Data can be seen in Table 2 for SBP, DBP, and
HR.) In addition to SBP, DBP, and HR, no significant dif-
ferences in group or time were observed for the ECG in-
tervals (RR, PR, and QT) or QRS duration. There were
no observed changes in ECG rate and rhythm patterns.
Subjective measures of mood state
Significant within group increases (p < 0.05) were ob-
served for both alertness (p = 0.026) and focus (p = 0.05)
at hour 1 and energy at hour 1 (p = 0.008) and 2 (p =
0.017) for DBX. Within group decreases in fatigue were
observed for fatigue for the DBX group at the hour 1
time point, and no significant within group changes oc-
curred for either hunger or concentration (p > 0.05).
Mood state data can be seen in Figure 3.
Discussion
The results from this study indicate that this particular
thermogenic aid is capable of significantly increasing
REE (+8%) for at least four hours post-ingestion in
moderate-level habitual caffeine consumers. It is reason-
able to contribute the increase in REE to the 340 mg
proprietary blend of caffeine anhydrous, guarana, yerba
mate, and green tea extract found in the commercially
available DBX. Caffeine is a known stimulant and
increases energy expenditure and weight loss. InTable 2 Hemodynamic Measures
SBP, DBP, and HR Measurements Baseline to HR4
SBP mean ± SD
(mmHg)
DBP mean ± SD
(mmHg)
HR mean ± SD
(bpm)





























































SBP, DBP, and HR were recorded at baseline, HR1, HR2, HR3, and HR4.
Measurements for SBP and DBP are reported as mean ± SD and recorded in
units of mmHg. Changes in SBP and DBP were not significant at any time
point for either group. Heart rate measurements were reported as mean ± SD
and recorded in beats per minute. Changes in HR were not significant at any
time point for either group.
Figure 3 Changes in reported mood states. a: Alertness was
reported on a 5-point Likert scale and rated one through five, five
being the highest. Changes in alertness for the active supplement
group were significant at HR1 only. * indicates statistically significant
changes (p≤ 0.05). b: Focus was reported on a 5-point Likert scale
and rated one through five, five being the highest. A significant
increase in focus was seen at HR1 for DBX. * indicates statistically
significant changes (p≤ 0.05). c: Energy was reported on a 5-point
Likert scale and rated one through five, five being the highest.
Changes in perceived energy were significant at both HR1 and HR2
for the supplement group. * indicates statistically significant changes
(p ≤ 0.05). d: Fatigue was reported on a 5-point Likert scale and
rated one through five, five being the highest. Decreases in fatigue
were significant for the supplement group at HR1. * indicates
statistically significant changes (p≤ 0.05).
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decrease body fat percentage and waist circumference in
overweight individuals [20]. Increased fat utilization as a
fuel source is another benefit often associated with
caffeine ingestion and supplementation. A 2011 meta-
analysis [21] concluded that while caffeine ingestion
increases energy expenditure, it appears to be unable to
increase fat oxidation unless paired with catechins. Fat
oxidation was significantly increased when 375 mg of
catechin was paired with 150 mg of caffeine [22], 540
mg catechin with 300 mg of caffeine [5], and when 662.5
mg of catechin was consumed with 270 mg of caffeine
[23]. The current study contradicts conclusions reported
by Hursel and colleagues [13] as the Dyma-BurnW
Xtreme supplement does contain a catechin-caffeine
mixture but RER was not significantly changed over the
four hour testing period (p > 0.05). This could possibly
be explained by the lower level of catechin (50 mg) used
in this particular product. More so, differences may be
attributed to the use of both men and women with vary-
ing resting RER levels. The results of this investigation
suggest that while DBX can promote a rapid and
sustained increase in REE, the increase is not due to en-
hanced fat oxidation. Research from 2001 [24] supports
the RER data from the current investigation as Graham
concludes that caffeine’s role as a glycogen sparing aid is
not fully supported by research.
The active supplement promoted increases in percep-
tions of alertness, focus, and energy, and also decreased
fatigue without impacting perceived anxiety levels. These
findings suggest that this product might have a favorable
impact on the perceived quality of daily activities includ-
ing exercise. Here again, caffeine is the most studied of
the active ingredients and believed to be the main con-
tributing factor to the positive changes in alertness,
focus, energy, and fatigue. In a study by Zwyghuizen-
Doorenbos and colleagues [25], a dosage of 250 mg of
caffeine increased alertness in healthy young men. Those
consuming the caffeine also performed better than those
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plement may be beneficial for persons looking to burn
more calories throughout the day and increase exercise
performance. Furthermore, the experimental design of
this study was based on an acute response and it is un-
clear at this time what the effects might have on chronic
exercise and training adaptations when the product is
taken for several weeks.
Of interest is the potential real world application of
this study considering all of the participants were habit-
ual caffeine consumers with a moderate daily intake of
caffeine (<200 mg/day) and were still responsive to the
active supplement treatment. This regular intake of
moderate amounts of caffeine may explain much of the
lack of observed hemodynamic and ECG effects in this
investigation. Tolerance to caffeine can develop within
four days of consuming 150 mg/day [26] and this built-
up tolerance can negate or reduce the side effects often
seen when a non-caffeine user ingests a caffeine-contai-
ning beverage/supplement including increases in SBP,
DBP, and changes in HR [27]. In addition to a lack of
negative physiological side effects, participants also did
not report any negative mood states or other side-effects.
When participants were given 280 mg of caffeine in the
form of coffee, Smits and associates [28] observed an in-
crease in BP and a decrease in HR, while there were no
significant changes among the control group (decaffei-
nated coffee). These changes in HR and BP were assumed
to be linked to the caffeine content of the regular coffee.
Considering the supplement used in the present study
contained 340 mg of total caffeine, habitual moderate caf-
feine usage seems to be the contributing factor to no sig-
nificant changes in HR, BP, and ECG data, as well as the
lack of reported side-effects.
Conclusion
In conclusion, when taken by moderate caffeine users
that are physically active and healthy, the proprietary
blend of this particular thermogenic supplement can in-
crease REE and mood states related to alertness, focus,
and energy without causing unsafe acute hemodynamic
side-effects or increasing perceived anxiety levels. Future
research should evaluate the chronic combined effects of
DBX with exercise.
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